Analysts Are Bullish on These Healthcare Stocks: Exact Sciences (EXAS), Neurocrine (NBIX)

TipRanksDec 16 22:20 · Ratings

Exact Sciences Is Maintained at Buy by B of A Securities

Dow JonesDec 14 00:22 · Ratings

BofA Securities Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $72

Futu NewsDec 13 21:33 · Ratings

10 BofA U.S. Options Overwriting Ideas

Seeking AlphaDec 12 01:31

Express News | Exact Sciences Corp : Leerink Partners Raises Target Price to $95 From $70

BreakingsDec 11 21:12

TD Cowen Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $86

Futu NewsDec 11 19:31 · Ratings